Patient-centered COAs Modus Outcomes specializes in concept-driven measurement and development of patient-focused COAs, presenting a clear opportunity to offer CRO services to sponsors seeking higher-quality, regulatory-friendly endpoints for high-stakes medical products.

Global reach With operations in the US, UK, and France and a flexible, international approach, there is potential to engage multinational sponsors and support global clinical programs, including regulatory submissions across regions.

DCT synergy Recent acquisition by Thread Research and emphasis on high-technology platforms suggests a strong fit for sponsors pursuing decentralized or hybrid trials that require robust COA data and integration with advanced trial technologies.

Rare disease focus HISTORY shows emphasis on PCOMs and multi-stakeholder collaboration with patients and families at the center, creating a niche for partnerships with rare disease programs needing specialized, patient-centered measurement solutions.

Smaller scale agility As a mid-sized firm with a focused team, Modus Outcomes can offer rapid, tailored engagement, cost-efficient COA development, and flexible consulting for early-phase programs or studies needing specialized measurement expertise not always available at larger CROs.